Q1 Results on Aug 09, 2016

| Updated on July 30, 2016 Published on July 30, 2016

Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on August 09, 2016, inter alia, to consider the following items of businesses and related matters:

1. Unaudited financial Results for the quarter ended June 30, 2016.

2. To Consider Interim Dividend, if any, for the year 2016-17.

3. Convening of 33rd Annual General Meeting for the financial year 2015-16.

4. Consideration of Employee Stock Option Scheme (NATS0P2016) under SEBI (Share Based Employee Benefits) Regulations, 2014

Further, TRADING WINDOW for dealing in the securities of the Company will be closed from August 01, 2016 to August 11, 2016 (both days inclusive). Trading window will be opened from August 12, 2016.

Pdf Link: >Q1 Results on Aug 09, 2016

Source : BSE - >

Published on July 30, 2016
This article is closed for comments.
Please Email the Editor